Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?

Published:2014-08-24 Issue:6 Volume:19 Page:887-893
ISSN:1569-9293
Container-title:Interactive CardioVascular and Thoracic Surgery
language:en
Short-container-title:Interact CardioVasc Thorac Surg

Author:

Xu Yong-jie,Zheng Hui,Gao Wen,Jiang Ge-ning,Xie Hui-kang,Chen Chang,Fei Ke

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Link

http://academic.oup.com/icvts/article-pdf/19/6/887/6125951/ivu262.pdf

Reference24 articles.

1. Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

2. Small-cell lung cancer

3. Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer

4. The Role of Surgery in the Treatment of Limited Disease Small Cell Lung Cancer: Time to Reevaluate

5. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: Long-term results of a phase II trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of surgical resection in the treatment of limited-stage small cell lung cancer: a multicenter retrospective study;Updates in Surgery;2023-12-03

2. Benefits and Relevant Risk Factor Assessment of Neoadjuvant Chemotherapy in Combination with Surgery in Limited-Stage Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023

3. Long-term results of postoperative unsuspected small cell lung cancer on real-world data;BMC Cancer;2022-12-02

4. Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer;Thoracic Cancer;2022-10-08

5. Chirurgie du cancer pulmonaire à petites cellules;Revue des Maladies Respiratoires;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3